Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

UNION HOSPITAL, INC.

NPI: 1306844519 · CLINTON, IN 47842 · Critical Access Hospital · NPI assigned 07/12/2005

$4.13M
Total Medicaid Paid
88,678
Total Claims
69,214
Beneficiaries
59
Codes Billed
2018-01
First Month
2024-11
Last Month

Provider Details

Authorized OfficialHOLMAN, STEVE (CEO)
NPI Enumeration Date07/12/2005

Related Entities

Other providers sharing the same authorized official: HOLMAN, STEVE

ProviderCityStateTotal Paid
UNION ASSOCIATED PHYSICIANS CLINIC, LLC TERRE HAUTE IN $30.99M
UNION HOSPITAL, INC. TERRE HAUTE IN $6.95M
UNION HOSPITAL INC MARSHALL IL $2.59M
UNION HOSPITAL INC BRAZIL IN $2.20M
UNION HOSPITAL INC. CLAY CITY IN $437K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 16,159 $363K
2019 11,545 $484K
2020 6,789 $335K
2021 10,793 $570K
2022 15,376 $907K
2023 17,952 $970K
2024 10,064 $503K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 7,993 6,319 $1.11M
99283 Emergency department visit for the evaluation and management, moderate severity 6,676 5,900 $1.05M
99284 Emergency department visit for the evaluation and management, high severity 5,247 4,387 $778K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 3,659 2,857 $203K
74177 Computed tomography, abdomen and pelvis; with contrast material 401 298 $143K
71045 Radiologic examination, chest; single view 1,513 1,185 $126K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 833 701 $100K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 1,095 863 $74K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 13,948 10,181 $70K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 1,785 1,409 $67K
71046 Radiologic examination, chest; 2 views 619 547 $60K
80048 Basic metabolic panel (calcium, ionized) 9,573 7,421 $53K
99218 141 97 $47K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 3,219 2,437 $39K
80076 4,915 3,887 $28K
84484 2,989 2,079 $23K
70450 Computed tomography, head or brain; without contrast material 290 247 $21K
96361 Intravenous infusion, hydration; each additional hour 1,773 1,355 $17K
80053 Comprehensive metabolic panel 2,886 1,992 $14K
81001 4,589 3,714 $13K
99282 Emergency department visit for the evaluation and management, low to moderate severity 61 53 $11K
87631 107 80 $10K
83690 2,499 1,975 $10K
83735 1,848 1,421 $8K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 339 270 $7K
87086 Culture, bacterial; quantitative colony count, urine 1,232 1,020 $7K
96375 Therapeutic injection; each additional sequential IV push 2,019 1,490 $7K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 243 194 $6K
G0378 Hospital observation service, per hour 26 26 $6K
74176 Computed tomography, abdomen and pelvis; without contrast material 33 25 $5K
84703 845 656 $5K
87400 600 479 $4K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 101 36 $2K
83605 310 224 $2K
94761 134 104 $2K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 181 162 $2K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 63 50 $1K
85610 325 279 $1K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 30 27 $818.31
81015 358 281 $663.32
80305 111 94 $586.97
87081 117 105 $581.47
83880 31 27 $446.85
81003 216 168 $348.51
J1885 Injection, ketorolac tromethamine, per 15 mg 657 520 $342.28
85652 147 120 $259.20
82550 61 42 $247.44
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 29 26 $125.60
85379 27 25 $114.82
94664 15 13 $90.97
85027 37 14 $76.68
J2405 Injection, ondansetron hydrochloride, per 1 mg 1,234 953 $71.70
J3010 Injection, fentanyl citrate, 0.1 mg 201 145 $34.42
82962 13 13 $29.42
85730 13 12 $19.47
J1100 Injection, dexamethasone sodium phosphate, 1 mg 60 39 $0.00
J0696 Injection, ceftriaxone sodium, per 250 mg 13 12 $0.00
J2270 Injection, morphine sulfate, up to 10 mg 182 143 $0.00
J1200 Injection, diphenhydramine hcl, up to 50 mg 16 15 $0.00